Highly Potent Active Pharmaceutical Ingredients (HPAPI)
2020-05-11 - 2020-05-12 | Copthorne Tara Hotel, Scarsdale Place, Kensington, London, W8 5SY, United Kingdom
SMi is delighted to announce its 4th Annual Highly Potent Active Pharmaceutical Ingredients conference coming to London on the 11th – 12th May 2020.
Announcement: Due to ongoing concerns over COVID-19 this conference is now available with remote access only – please register your place at www.highlypotentapi.com
The price to be a part of this conference is £999 (remote access) and registration is available via the conference website www.highlypotentapi.com

HPAPI 2020 conference focuses on the growing landscape driven by the demand for highly potent drugs in oncology, diabetes and autoimmune disease treatment. This event will address the biggest challenges the industry is facing with regards to determining toxicology limits, assessing hazards, implementing risk procures, translating risk assessment into facility engineering, preventing and dealing with cross-contamination and adhering to GMP regulatory guidelines.
Attend the conference and join our networking platform for industry professionals to provide you with the expertise to overcome the challenges of the HPAPI industry.
Network and learn from leading professionals such as:
CHAIR FOR 2020 – Justin Mason-Home, Director, HPAPI Project Services Limited
KEY SPEAKERS INCLUDE:
Pascal Michoux, Vice President, Global EHS Teva api & Biologics, teva API Italy
William Hawkins, Manager Occupation Toxicology, GsK
Brian Edwards, Chair, Pharmaceutical Human Factors Group, CIeHf
Thomas Adam, Head of GQA Chemical APIs, Bayer AG
Ildikó Ziegler, QA Manager, Gedeon Richter
Francois D’Hooge, ADC Project Manager, Gamamabs Pharma
Andreas Schreiner, Head of Validation, Novartis
FEATURED HIGHLIGHTS:

Explore HPAPI manufacturing with 8 big pharma from both the toxic substance and the employees’ perspective
Gain better understanding of human factors and ergonomics aspects and their role in improving production performance with the Chartered Institute of Ergonomics and Human Factors
Deep dive into the oncology market and ADC production, the main driver of the HPAPI industry
Learn what it takes to create a safety company culture and how to better train your employees on risk perception

View the full agenda: www.highlypotentapi.com
Contact Info:
T: +44 (0) 20 7827 6164
E: nhoward@smi-online.co.uk

4th Annual Global Clinical Trials Connect 2020 - Collaboration, Innovation and Enhancing Quality in Clinical Trials
2020-05-13 - 2020-05-14 | Holiday Inn London – Kensington High St. Wrights Ln, Kensington, London W8 5SP, UK
The 4th Annual Global Clinical Trials Connect 2020 will provide a platform to discuss on the futuristic advancements in clinical trials and clinical research. This multidisciplinary program involves broad participation of people from clinical trials community from around the globe who are focused on learning more about clinical research, clinical trials planning and management.
Key Highlights

Patient Recruitment and Site selection
Innovative trial designs
Partnership & Collaboration – Sponsors, CROs, Sites and External Vendors
Patient centric clinical trials
New innovations in Patient Recruitment planning and execution on a clinical trial
Outsourcing strategies and models
Electronic Clinical Outcome Assessment and Electronic Patient Reported Outcome
Streamlined IRT development process
Pharmacovigilance & Clinical Trials
Post-Clinical Trial closed communities
How to future proof your clinical operations
Implementing Risk Based Monitoring
Streamlining R&D and lower costs in clinical trials
Adaptive Trial Model
Clinical Trial Auditing
Real World Clinical Trial Strategies
Data Quality & Technology
Clinical Data Strategy & Analytics
Clinical Technology and Driving Innovation
M-Health, Wearable and Consumer Technology
Big-Data, IoT and Artificial Intelligence Technology in Clinical trials
Blockchain technology for improving clinical research quality

Outsourcing in Clinical Trials East Coast
2020-05-19 - 2020-05-20 | Valley Forge Casino Resort – 1160 1st Ave, King of Prussia, PA 19406, United States
Discover effective strategies for outsourcing clinical trial operations to ensure studies run smoothly and within budget

Arena International are delighted to announce Outsourcing in Clinical Trials East Coast will be returning to King of Prussia in May for its 11th Annual event!

The 2020 programme will feature a range of speakers from the likes of GlaxoSmithKline, Novartis, Pfizer, BMS any many more, who through a variety of interactive session formats will offer insight on promoting successful collaboration between the clinical trials community. Attendees will have the opportunity of taking part in sessions across 3 stages, each focusing on a different topic area. Whether your role is Clinical Operations, Technology & Innovation or Clinical Data Management this event can not be missed

We look forward to seeing you there!

Digital Health Online Summit
2020-05-25 - 2020-05-30 | Online
The healthcare industry will never be the same after COVID19.
Healthcare professionals need to stay aware of the latest digital health activities and keep learning from leading organizations.

Digital Health Online Summit is a 6-day virtual summit, providing a comprehensive overview of the current digital health activities, and equipping health professionals with strategies and tactics, examples and guidelines for a successful healthcare transformation.
This online summit will provide you with timely insights into the following areas:

Digital Health – Current Activities in different organizations
Smart Care, Patient Centricity and Engagement
Transformation with VR/AR, Voice Tech, IoT, Wearables
Big Data, AI and Machine Learning
The digital mindset transformation
Patient staff engagement and culture change
New Horizon, Innovation and Tomorrow’s Perspectives

Within each topic, there will be 5-9 speaking sessions, using case studies and bringing practical examples. The summit will gather 40 expert speakers from great companies and associations from all around the world, including Europe, North America and Australia.
While the standard events require a lot of time, effort, logistics, and significant expenses for travel and accommodation, Digital Health Online Summit takes advantage of today’s technologies and provides the best content for professionals from all around the world.
To mention just some of the speaker’s companies: United Health Group, HNS, Dignity Health, European Health Management Association, WONCA, Stanford Virtual Human Interaction Lab, XpertCare Inc., Seton Health Alliance, Deloitte, KPMG, Mednax, Crossroads Hospice & Palliative Care, CitiusTech, Partners HealthCare, Peninsula Regional Health System, Philips, Ramsay Santé and others.
This is a great possibility to learn directly from C-Suite executives with unique and timely insights about the digital shift towards better health services.
Here are just some of the case studies and presentations:
➤ Visions and Strategies for Virtual care services
➤ Current Challenges of Digitalization in the Healthcare Industry
➤ Key components of a successful digital transformation strategy
➤ How to keep the conversation open with HCPs while they are not available (COVID-19 crisis time)
➤ Frontline digital healthcare strategy – from business as usual to crisis management
➤ Digital when possible – physical when needed
➤ Personalized, digitally-supported, out- of-hospital care: A patient case study
➤Digital Therapeutics: Just Like a pill?
➤ Innovation in times of a global crisis
And much, much more.
For our members and network, we have FREE REGISTRATIONS to this great online summit.
Get your FREE PASS here >> https://www.digitalhealthonlinesummit.com/?utm_source=partner
Hope you can join the event!

Microbiome Connect: Human
2020-06-03 - 2020-06-04 | Boston, MA, MA, United States
Previously known as North American Microbiome Congress, Microbiome Connect: Human USA is all about connecting leading academics and biotech companies presenting preclinical and clinical data, to network, educate and share knowledge. Join key opinion leaders and 50+ expert speakers across three dedicated tracks of content to examine the latest preclinical and clinical data in extra-intestinal and intestinal indications.
To know more about Microbiome Connect: Human please click here.

Microbiome Connect: Skin
2020-06-03 - 2020-06-04 | Boston, MA, USA
Microbiome Connect: Skin | 3 – 4 June 2020 | Boston, USA

2019 was a pivotal year for the skin microbiome, with multinational conglomerates moving into the space, recognizing the commercial value of skin microbiome-based products as the next step in a consumer’s skincare regime but the innovation doesn’t end there…
This year is all about the major advancements of sequencing and analysis in this space, and how we can use data to inform product development. 2020 is all about the relationship between skin microbiome based-products, skin conditions, personalization, skin-gut supplements, and anti-aging.
Building on the hugely successful global Skin Microbiome series which brought together over 600 industry leaders from Pharmaceutical, Beauty and Personal Care, Independent Skincare Brands, Bio-techs, Researchers and Academics, Kisaco Research presents Microbiome Connect: Skin USA, an all-encompassing event, which runs alongside Microbiome Connect: Human USA in Boston, June 3 – 4.
To learn more about this event and to register online, visit http://bit.ly/3a9rICR

HR Life Science Virtual Event
2020-06-04 | Online, Noon EST
The HR Life Sciences Virtual Event is a WFH friendly forum covering a range of topics affecting HR strategy and talent management, including telework, employee communication, training or re-training – and of course crisis management as we navigate these unchartered waters. We want to provide you with insights and resources from your peers working through unprecedented challenges at their organizations.
Whether your current work environment is a home office, kitchen table, or hiding from the kids in your bathtub, you can join HR leaders from a diversity of pharma, biotech and medical device companies (whether live or at your own pace!) as we chat through front-of-mind topics and solutions.

ACI’s Skin Microbiome Industry Summit
2020-06-17 - 2020-06-18 | London, UK, United Kingdom
Skin microbiome products have been gaining more momentum in the last few years with more brands starting to develop products, and personal care giants either starting to develop their own product or investing in start-ups focusing on these. It is a very exciting time for companies looking into this at the moment, figuring out not only product development & formulation but also marketing strategy to raise more attention to this type of products. Despite huge popularity and early success stories, there is still a need to learn more on topics such as: defining the skin microbiome, formulating products, cosmetics & pharma claims, regulation for novel products, latest advances in terms of mapping & profiling technologies, as well as product testing.

ACI’s Skin Microbiome Industry Summit, taking place on the 17th & 18th June 2020 in London, will bring together the key actors of the industry to help the industry learn from one another, work together to further grow and create new business opportunities. During the 2 days conference, the participants will enjoy the various case studies presentations, panel discussion, Q&As and networking breaks to get the industry to thrive together. Join us in London for a highly interactive & informative conference, whilst enjoying the networking opportunities with your peers.

CPhI & P-MEC China 2020
2020-06-22 - 2020-06-24 | Shanghai New Int’l Expo Centre (SNIEC), 2345 Longyang Road, Shanghai, China
CPhI & P-MEC China is your gateway to successfully grow your business at the 2nd largest pharma market in the world and your ONE-STOP SHOP pharmaceutical platform connecting the entire pharmaceutical industry chain. On 22-24 June 2020, CPhI China 2020, collocated with ICSE China, NEX China, and P-MEC China, will continue its glorious journey and celebrate its 20th anniversary at Shanghai New International Exhibition Centre (SNIEC). The show is to cover an exhibition area of 210,000 sqm and is expected to draw 3,400+ exhibitors from over 140 countries and regions and 75,000+ visits from global industry professionals.
To learn more about CPhI & P-MEC China and to register online, visit www.cphi-china.cn/en

JAK Inhibitors Drug Development Summit – Running Digitally for 2020
2020-06-24 | Online
Despite the increasingly unpredictable nature of COVID-19, our commitment to provide educational resources and networking experiences to keep pharmaceutical knowledge thriving and the industry moving forward has not wavered.

Therefore, we are very excited to announce that the JAK Inhibitors Drug Development Summit has been transformed into an exclusive one-day digital event that will immerse you in discussions on developing the next generation of JAK inhibitors to expand their clinical utility across oncology, dermatology and autoimmune disease indications.
This is your one and only cross-disciplinary JAK inhibitor meeting with all the content and networking opportunities now delivered in a digital format.
Our community of JAK inhibitor experts are looking forward to connecting with you in the digital world, including:

Leandro Santos, Associate Director, Clinical Sciences Incyte
Maciej Wieczorek, Chief Executive Officer, Celon Pharma
Piet Wigerinck, Chief Scientific Officer, Galapagos
Anabela Cardoso, Global Brand Development, Lead – Immunology, Eli Lilly
Brett King, Associate Professor of Dermatology, Yale School of Medicine
Massimo Gadina, Chief Translational Immunology Section, National Institute of Arthritis & Musculoskeletal & Skin Diseases

Don’t miss this opportunity to hear about the latest data shared by peers, and take advantage of the online networking and ‘Ask the Expert Speaker’ chatrooms.
Visit the website to learn more and secure your place: https://ter.li/o6ghqw

Onco Cell Therapy Summit
2020-07-07 - 2020-07-09 | Virtual, EDT Timezone
Onco Cell Therapy Summit (OCTS), formerly the CAR-T Congress, is the leading digital event revolutionizing patient outcomes in cancer therapies.
This virtual summit, taking place June 7 – 9, spans across 3 half days, bringing you opportunities to share novel research, manufacturing techniques and regulatory best practice through virtual panel discussion, traditional presentations, polls and round tables, all from the comfort of your own home. Each session at OCTS 2020 is dedicated to encouraging knowledge sharing and translating novel data assets and IP into commercially viable oncological therapies.

OCTS is a 4-track event and whilst bringing together the key decision makers for CAR-T therapies, it also focuses on ground breaking science that is driving the surge of interest in harnessing alternative cell therapies in cancer treatments.
With 2 of our tracks comprised of research on CAR-T and alternative cell therapies, the other pillar in rolling out these therapies is increasing the affordability of the treatments. The other two tracks will delve into best practice in commercialization and manufacturing of immuno-oncological cell therapies.
Each day includes plenty of opportunities to network and there’s multiple panel discussions to also take a deep dive into the key challenges in major topics to R&D, manufacturing and commercialization.
This is one must attend virtual event in the cell therapy field.

Direct to Patient and Virtual Clinical Trials – Digital Experience
2020-07-09 | Virtual Event
With COVID-19 creating worldwide disruption in clinical trials and companies looking for innovative approaches to keep trials going, we at Arena International are delighted to announce the launch of our Direct to Patient and Virtual Clinical Trials Digital Experience.

This one-day online event will bring together top-class speakers from around the world to discuss themes including remote monitoring, temperature control in direct-to-patient shipments, regulations and compliance, and how to engage patients throughout a virtual trial.
Alongside listening to presenters in our auditorium, attendees will have the opportunity to visit our virtual exhibition hall, chat in our networking lounge, and set up 1:1 business meetings.
This event will be a crucial platform for clinical trials professionals to learn about how to adapt to direct-to-patient and virtual trials in a COVID and post-COVID world, making it an unmissable event in your calendar.

Clinical Operations In Oncology Trials
2020-07-15 | Vitual Event
To keep pace with the health needs of the growing number of young and old afflicted with cancer globally, clinical development in oncology is one of the fastest growing areas within the Pharma industry. At this unique virtual event, attendees will get to learn strategies to better manage communication and relationships between trial sponsors and CROs, learn ways to create patient-centric trials for higher enrolment rates including addressing the need for more diverse recruitment and much more. Key presenters on the line-up consist of C-level and director-level executives from the likes of Tufts Medical School, Beat AML, Pfizer and Agios Pharmaceutical.
URL: https://arena-international.com/oncologyvirtual/

Gene Therapy for Neurological Disorders Europe
2020-07-15 09:00 - 18:15 (Europe/Paris)
Gene Therapy for Neurological Disorders Europe is dedicated to solving the translational drug development challenges encountered in the development of gene therapies for neurological disorders.

Industry pioneers from the leading pharma and biotech companies including Avexis, uniQure, and Biogen will share how to improve the translatability of small and large animal models, develop innovative delivery approaches to guarantee delivery of vector and understand the realities of immunogenicity challenges in the CNS.
Join this definitive, niche digital conference to accelerate the development of your gene therapy pipeline and address the significant unmet need in neurological indications.

Prefilled Syringe Elastomer Components - High-quality Solutions for Sensitive Molecules
2020-07-16 | Webinar
Join the experts on this free exclusive webinar on the 16th July 2020 at 2pm BST, hosted by West Pharmaceutical Services, Inc.
As the industry continues to see significant growth for drug products developed in prefilled syringe systems (PFS), there is a trend for pharmaceutical companies to evaluate more complex drug molecules, such as biologics.
This webinar discusses current trends in the market for injectable drug delivery and outlines current challenges for companies developing drug products in a prefillable syringe system.

Webinar Overview
Increasing demands on quality, stringent regulations, trends towards home care treatments by using innovative device technology, and the development of specialized, high-value treatments present challenges to companies looking for unique solutions.
In this webinar we will cover new elastomer component leading with innovation excellence developed to address the ever-increasing demands. Discussing the challenges of the pharmaceutical industry driven towards components being essentially free of particulate and meeting customer demand for consistency by assuring dimensional stability.
For more information on the webinar and to register your free place, please visit: www.pfs-elastomer-components-webinar.com/mp

Medical Device Trials
2020-07-16 | Virtual Event
At our first Medical Device Trials virtual event our aim is to support trial sponsors and solution providers internationally to ensure trials are delivered on time, partnerships are improved and innovations are showcased, discussing, deliberating and debating the latest operational and technological challenges with regards to clinical trial in medical devices. Hear talks from Bassil Akra, Faouzi Kallel from Edwards Lifesciences and many other industry leaders and disrupters!
URL: https://arena-international.com/ctmd/

EXCLUSIVE FREE WEBINAR ON Prefilled Syringe Elastomer Components High-quality Solutions for Sensitive Molecules
2020-07-16 | Webinar
Join the experts at this free exclusive webinar on the 16th July 2020 at 2pm BST, hosted by West Pharmaceutical Services, Inc.We have had over 90 registrations so far, joining us from:Abbvie, Aptar, Aptar Pharma, BI Pharma GmbH & Co. KG, BioQ Pharma Inc, Datwyler, DEKRA, Hikma Pharmaceuticals, j8 Process Consulting Taiwan, Janssen, Kansai Plascon, Lazard, Lilly, Nemera, Novartis, Ohio State University, Pfizer Inc, Regeneron, Roche, Sanofi, Sanofi Pasteur, Schott, SCHOTT France, Sio2 Materials Science, Softeq, Sumitomo Rubber North America, Sun pharma research center, TUV Italia srl, TUV Italy, Vetter Pharma-Fertigung GmbH & Co. KG, Weiss-Aug Co, Inc., WL Gore, Zacros (Fujimori Kogyo co. ltd.) and many more!
With only less than 2 weeks to go, if you haven’t already registered your FREE place book your virtual seat here today!Can’t make the date/time? Register your place at the above link and we will send you the webinar, post event.
Webinar OverviewIncreasing demands on quality, stringent regulations, trends towards home care treatments by using innovative device technology, and the development of specialized, high-value treatments present challenges to companies looking for unique solutions.In this webinar we will cover new elastomer component leading with innovation excellence developed to address the ever-increasing demands. Additionally, we discuss the challenges of the pharmaceutical industry driven towards components being essentially free of particulate and meeting customer demand for consistency by assuring dimensional stability.Expert Webinar Hosts from West Pharmaceutical Services, Inc.Christa Jansen-Otten,Product Management, Prefilled Systems & DeliveryWhitney Winters,Senior Director, Strategic Marketing and container SystemsFind out more information on the webinar hosts here.
For more information on the webinar and to register your free place,
please visit: www.pfs-elastomer-components-webinar.com

Innate Immune Stimulating Therapies Summit – Running Digitally for 2020
2020-07-22 | Online, MA
Safely Harnessing Novel Targets of the Innate Immune System for Enhanced Anti-Tumor Effects
The inaugural Innate Immune Stimulating Therapies Summit is focused on achieving safe and effective clinical and commercial translation of STING and TLR therapies.

Join the leaders in the field, from key biotech, large pharma, and academia, to discuss how to optimize the administration of innate immune stimulating therapies from IT delivery through to antibody conjugated approaches.
If you are looking to make long lasting connections with industry leaders and take part in discussions about the lessons learned on the journey to translating safe and effective innate immune stimulating therapies for patients in need, then this is the meeting for you. Join our online community of industry experts here: https://ter.li/52s56v. Earlybird and group discounts apply. Book early to secure the best possible rate on your ticket.

RNAi-Based Therapeutics Summit – Running Digitally for 2020
2020-07-22 | Virtual Event
Digitally Join the RNAi-Based Therapeutics Community
We are excited to announce that the RNAi-Based Therapeutics Summit has gone virtual!
As the first multi-disciplinary discussion for large pharma, biotech and academic leaders specifically dedicated to the RNAi therapeutics, the industry will be coming together on Wednesday, July 22 to successfully optimize cell-specific strategies, overcome pharmacology and delivery challenges to accelerate translation and clinical development of RNAi therapeutics in the liver, CNS and beyond.
Check out the official event guide for full speaker and session details.
Join this virtual summit to meet those pioneering the field and to hear from 19+ world-class experts that are sharing their latest perspectives:

Dong-ki Lee, Founder & Chief Executive Officer, OliX Pharmaceuticals
Elena Feinstein, Chief Scientific Officer, Quark Pharmaceuticals
Karyn O’Neil, Chief Scientific Officer, Aro Biotherapeutics
Brooke Rock, Director, Amgen
Sharmistha Ghosh, Associate Director, Arrowhead Pharmaceuticals
Baisong Mei, Senior Global Project Head, Sanofi
David Corey, Professor, UT Southwestern

Download the updated program to see the full list.
With several clinical candidates emerging and momentum building in the field, join the RNAi-Based Therapeutics Summit – your comprehensive, industry-focused virtual meeting dedicated to bringing together senior biopharmaceutical leaders from discovery, translation, and clinical development functions to advance pioneering RNAi platforms that improve patient outcomes. Secure your ticket now.
Looking forward to seeing you at our virtual meeting!

Gene Therapy Immunogenicity
2020-08-04 - 2020-08-06
Gene therapies are revolutionizing the therapeutic landscape for rare and inherited diseases. For the field to progress, however, there are several unique and complex challenges. Perhaps the most prominent of these challenges is the immune response to gene therapy delivery.

The inaugural Gene Therapy Immunogenicity Summit is the industry’s definitive forum enabling you to better measure, modulate and predict immune response to your gene therapy candidate.
Uniting industry leaders across the gene therapy space, this multi-disciplinary forum will enable you to develop more effective and safe gene therapies by discussing how you can:

Identify and tailor novel capsid proteins for more specific targeting and immunologic evasion
Reduce AAV neutralizing antibodies
Confidently assess immunosuppression strategies to dampen immune response

As the only conference dedicated to the immunogenicity of gene therapies, this will be an unrivalled opportunity to join 80+ like-minded thought-leaders from cross-disciplines to foster new connections and partnerships.
Download the full event guide to learn more from companies including BioMarin, Spark Therapeutics and Novartis.

Vaccines Virtual Conference
2020-08-12 | Virtual Event
Due to the current climate, we have taken the initiative to launch our very first vaccines conference! Join industry experts from across the globe, conversing in the latest innovations in COVID-19 and other leading vaccine studies. Brought directly to your home – listen to leading organisations such as GlaxoSmithKline, Sanofi, Pfizer along with leading biotech’s and is completely FREE! Featuring sessions COVID-19 Vaccine Updates, overcoming manufacturing challenges within the industry , managing clinical trials during a pandemic, consideration needed in commercialising your vaccine and more, this event is crucial to ensure you are up to date with the latest developments in the vaccine space.

URL: https://arena-international.com/vaccine-virtual/

Hemophilia Drug Development Summit – Running Digitally for 2020
2020-08-18 | Virtual Event
With the recent Hemlibra approval and the gene therapy revolution, we are seeing a much-needed race to innovate more effective, long-lasting and curative therapies for hemophilia and acquired bleeding disorders.
As such, the 3rd Hemophilia Drug Development Summit is going digital and remains dedicated to bringing to patients more effective commercially and clinically translated therapies from small molecules to gene therapies to improve patients’ quality of life.

Bringing together over 100 of the world’s leading experts and drug developers, we discuss how to develop new therapies for a responsive subset of hemophiliac patients, optimize clinical trial development (setup and management) and discuss the patient/payer paradigm to ensure these novel therapies are affordable and accessible.
Brought direct to your home office with a jam packed agenda and online virtual networking opportunities, this exclusive virtual summit will delve into the challenges of treating each patient subset, as well as hearing the latest advancements in gene therapy and discussing the critical hurdles that need to be overcome to meet the unmet clinical need of all patients.
Join us as we unite drug developers and researchers on a dedicated online platform and look to the innovation driving the field towards more long-acting and curative therapies to improve patient quality of life.
To know more about Hemophilia Drug Development Summit please click here.

TIGIT Therapies Digital Consortium
2020-08-27 | Online
Priming the immune system against solid tumors by leveraging immune checkpoint blockade has proven to be an effective tool in multiple malignancies.
Following the success of PD1/PDL1 checkpoint inhibitors a new wave of ICI now enters the clinic, amongst which TIGIT has shown exciting preliminary results and sparked great excitement in this nascent field. With 27 ongoing clinical trials investigating TIGIT in front- and second-line indications, a great deal of momentum has built in this competitive space.

However, core challenges must still be addressed by the community, such as:

Investigating the TIGIT pathway, ligands, and modes of action
Optimizing biomarker strategy to identify optimal patient populations and indications
Rationalizing combination strategy to leverage the TIGIT mechanise for maximum therapeutic benefit

The TIGIT Therapies Digital Consortium will gather the greatest minds in TIGIT research in a series of monthly, themed seminars. Gain access to 1:1 time with leaders in TIGIT research and take away tangible learnings with monthly executive summaries and exclusive content after the event.
In such a fast-paced industry, this is a unique opportunity to provide an overview of the ‘knowns and unknowns’ in the field and draw a path for best practice in the safe development of TIGIT therapies with maximum clinical impact.
Working with leaders in the industry we have developed a series of working groups that bring together the best and brightest minds within the development of TIGIT therapies to bring you the opportunity to share invaluable insights, leverage the collective experiences of years of expertise and network and collaborate with the movers and shakers; all with the ultimate aim of accelerating the clinical to commercial development of TIGIT therapies.
At a time when we are more isolated than ever, these working groups will break down barriers and provide the opportunity for frank and open discussion to ensure the continued progress and development of TIGIT therapies.
Head to the TIGIT Therapies Digital Consortium website to access your complimentary event guide and find out more!

Blood-Brain Barrier (BBB) Summit
2020-08-31 - 2020-09-02 | Virtual Event
Going digital in its 2nd year, the Blood-Brain Barrier (BBB) Summit is the industry’s definitive BBB conference focused on sharing the latest scientific advances, data and key lessons learned for transporting more drugs across the BBB.
With a heavy focus on biologics, for neurodegenerative diseases, this summit will discuss topics such as quantitative methodologies for measuring amount and distribution of antibodies in the brain, using PKPD systems to improve translation and predict clinical outcomes and importantly, progress in the validation of approaches and technologies which enhance BBB transition.
Moreover, this meeting also aims to deepen your understanding of intracellular trafficking and receptor binding, pharmacokinetics and protein engineering to drive the clinical applicability of receptor mediated transcytosis. The 2nd BBB Summit delves into identifying gaps in the physiology of the BBB and questions the extent of the relationship between the BBB and different disease states in various neurodegenerative diseases as well as uncovering what makes neural exosomes efficient BBB drug delivery tools.
Join fellow BBB specialists virtually to scrutinize progress of existing approaches to deliver more of your biologic therapeutic across the BBB to develop a clinically defining neurodegenerative treatment.
Take a look at the full event guide here.

ProcureCon Pharma 2020
2020-09-03 - 2020-09-04 | HOTEL PALACE BERLIN, Germany
Taking place on 3 – 4 September 2020 in Berlin, ProcureCon Pharma is your only opportunity to benchmark with the leaders of pharma procurement.
Join 120+ senior procurement professionals from Merck, Astra Zeneca, Roche, Sanofi, Lonza and other world leading Pharma businesses over 2 days and 40 interactive sessions that will help you make better outsourcing decisions, speed up transformation, co-create value with business partners and unlock more innovation from suppliers. To learn more about ProcureCon Pharma, download the agenda.
Take away answers to all of your top challenges:

Deliver on and communicate value-added procurement activities to increase credibility as a business partner
Identify and adopt eProcurement technologies to modernize procurement
Move from buyers and sellers to long-term strategic partners through SRM and Supplier-Led Innovation

For more information including the incredible speaker line-up, download the agenda here: http://bit.ly/2mnKKSw
Book your place online today: http://bit.ly/2kR13a2 and get 15% off the current ticket price with our exclusive discount code – “PJOURNALIST20”

Glioblastoma Drug Development Summit
2020-09-08 | Online
After an exceptionally successful inaugural launch last year, the 2nd Annual Glioblastoma Drug Development Summit returns this year in an exclusive virtual format.
GBM Drug Development is the only devoted meeting for large pharma, biotech and pioneering academics which guarantees to unite all stakeholders under a mutual and ambitious objective of accelerating the practical discovery, translation, and clinical development of safe, effective and deliverable therapies to treat glioblastoma, an extremely aggressive cancer with a huge medical unmet need.

Confronting specific and applied drug development obstacles with inadequate successful treatments, such as the knowledge of glioblastoma’s mechanisms of resistance and lack of penetration via the blood brain barrier, the 2nd Glioblastoma Drug Development Summit will help neuro-oncologists, neurosurgeons and oncology professionals from biopharma effectively translate their drug candidates into human clinical trials, whilst optimizing the clinical development process itself to evade further clinical failures.

Brought direct to your home office with a jam-packed agenda and online virtual networking opportunities, this exclusive virtual summit will delve into the common challenges with developing GBM therapies, whilst striving to advance safe and effective therapeutic breakthroughs to patients in need.

To know more about Glioblastoma Drug Development Summit please click here.

Pre-filled Syringes San Francisco
2020-09-14 - 2020-09-15 | Virtual Event
SMi is proud to announce the inaugural Prefilled Syringes San Francisco event taking place in September 2020.
The global pre-filled syringes market was valued at $4.9 billion in 2018 and with the rapid growth of the industry, is expected to exceed $9.7 billion by 2025. With that in mind, this event will bring together specialists within the industry to provide an exclusive insight into the sphere of regulation, new digital technology trends, human studies and innovative design and delivery systems within the prefilled syringe industry.

As part of SMi’s leading Injectable conference series, we will assess digital health and connected devices, biologics, biosimilars and biocompatibility for drug device combination products, platform and device selection, regulatory insights and explore the West Coast’s biotech innovators.
This two-day agenda offers you peer-to-peer networking with Global Product Managers, Device Testing Managers, Senior Device Engineers, Heads of Device Development, Heads of Formulation and Drug Process Development, and many more.
Plus, a workshop on human factors and risk management:

Integration of Human Factors Engineering processes in risk management saves time and money in product development
Effective identification of use-related risk helps inform constructive design decisions
Mitigation of use-related risk improves treatment outcomes for end users
Understanding the methods used to assess use-related risk will improve the efficiency and acumen of your organization

Benefits of attending:

EXPLORE the latest industry case studies in platform approaches and connected devices
GAIN insights from leading industry and regulatory experts on the pre-filled syringes environment
HEAR from local biotechs of San Francisco and the West Coast to learn about new innovations in the pre-filled syringes space
ENGAGE in the key challenges and topics of the field in two interactive half-day workshops

Chairs for 2020:

Shannon Clark, Principal, UserWise
Steven Badelt, Founder and Managing Partner, Suttons Creek, Inc.

Featured 2020 speakers include:

Kristina Lauritsen, Combination Products Regulatory Advisor, FDA/CDER
Manuela Gazzard, Group Executive Director Regulatory Services Healthcare, BSI
Christine Lynn Lanning, Distinguished Scientist, Device Area Leader, Safety Assessment/Merck & Co., Inc
Khaudeja Bano, Senior Medical Director, Abbott Laboratories
Jace Blackburn, Smart Device Engineer, Genentech
Michael Koby, Senior Principle Scientist, Pfi zer
James Leamon, Director of Biologics Device Development, Jazz Pharmaceuticals
Walter Goodwin, Device Engineer, Device Development & Clinical Packaging Engineering, Gilead Sciences
Katie Atkinson, Manager Human Factors Engineering, Bigfoot Biomedical

EARLY-BIRD RATES:

BOOK BY 30TH APRIL AND SAVE £600
BOOK BY 29TH MAY AND SAVE £300
BOOK BY 30TH JUNE AND SAVE £200

Additional Contact Info:
T: +44 (0)20 7827 6088
E: hsidhu@smi-online.co.uk
LinkedIn: @SMi Pharma
Twitter: #smipfsusa

Future Pharma 2020
2020-09-14 - 2020-09-15 | Boston Marriott Long Wharf, 296 State Street, Boston, MA, 02109, United States
Future Pharma
September 14 – 15, 2020
Boston Marriott Long Wharf, Boston, MA
www.pharmaforce.wbresearch.com

Future Pharma is a two-day event that brings together heads of brands and franchises, marketing, sales and digital executives from leading pharmaceutical companies in an interactive and energizing setting. It is the only conference designed to help commercial leadership evaluate their personal and non- personal promotions, align marketing and sales strategies and provide insight on commercial success in a post-pandemic industry landscape.
With limited vendor attendance and presentations, you’ll experience true pharma-to-pharma networking in an interactive format. And by selecting sessions based on the topics you care about most, you’ll connect with other marketing and sales executives who are focused on having the same, critical conversations.
For more information on Future Pharma 2020, download the agenda: bit.ly/2Vt69aL
Register now and SAVE 25% on your conference pass using our exclusive discount code FP20PJ: https://pharmaforce.wbresearch.com/srspricing

2nd Annual RAS – Targeted Drug Development – Digital Summit
2020-09-14 - 2020-09-16 | Digital Event
Via the latest data driven case studies from academic and industry pioneers, the 2nd RAS Targeted Drug Development Summit (running digitally this year!) will shine a spotlight on optimizing the selectivity and tolerability of your anti-RAS therapies, exploring novel combination strategies and overcome translational pharmacology challenges to set the stage for the 2nd generation of mutation-targeted RAS modulating therapies yet to come.

Explore how to leverage the internal structural biology of RAS mutations in order to produce effective and clinically viable therapies with discussions from E Shaw Research, The Johns Hopkins University School of Medicine & Hospital for Sick Children
Deep dive into RAS associated pathways in order to optimize combination therapies with insights from Novartis, Genentech & Deciphera Oncology
Evaluate the mechanisms of action and resistance of RAS targets to accelerate target validation and clinical translation with insights fromAbbvie, PhoreMost & Verastem Oncology
Adopt novel techniques to successfully target therapeutic vulnerabilities in RAS-driven cancers with lessons learnt from BeiGene, Genentech, Revolution Medicines, Oblique Therapeutics & Aro Biotherapeutics
Explore the successes and future therapeutic potential of targeting mutation beyond G12C from within the RAS community explored Revolution Medicines, Francis Crick Institute & MD Anderson Cancer Centre

Following the success of RAS-Targeted Drug Discovery Summit in 2019, we will re-unite the RAS community virtually this coming September with the most comprehensive and definitive conference specifically dedicated to this community.
Join 250+ of the leading minds from large pharma, biotech and academia across the globe who are striving to capitalise on the therapeutic opportunity of targeting RAS through advancing novel mechanisms of action, improving drug-like properties and accelerating the translation of potent and mutation-targeted 2nd generation RAS targeted therapeutic strategies into human clinical trials.

TIDES: Oligonucleotide & Peptide Therapeutics 2020
2020-09-15 - 2020-09-18 | 100% Virtual
The #1 event for oligonucleotide, peptide, CRISPR and mRNA therapeutic leaders. Join us for top-notch networking, high-level industry expert speakers, innovative company presentations, interactive scientific poster presentations, and diverse attendee companies and investors — in a multi-day digital format that you can access from anywhere in the world.
